Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein production ...

In May 2022, The US FDA authorized the use of RADICAVA ORS (edaravone) in an oral formulation for the treatment of ALS.

Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein production, a process that fails in amyotrophic lateral sclerosis (ALS).

The Ohio mother and former teacher used her final months to write lessons for her sons and to help others living with ...

The amyotrophic lateral sclerosis market is expected to grow owing to the increasing prevalence of the disease, along with the promising emerging pipeline therapies, such as Masitinib (AB Sciences), ...

Currently, the MyoRegulator® device is under investigation as a non-invasive treatment for ALS in a second and larger clinical trial, the CALM ( C ontrolling A myotrophic L ateral Sclerosis M otor ...

NRG Therapeutics has dosed the first participants in its Phase I clinical trial of NRG5051, being developed as a ...

Ractigen Therapeutics is pleased to announce that the first patient has been dosed in the Phase II clinical trial of RAG-17, an innovative siRNA therapy targeting SOD1-mutated amyotrophic lateral ...

NEW YORK, March 13, 2023 /PRNewswire/ -- ANEW MEDICAL, INC. ("ANEW'' or the "Company"), a medical product development company (OTC:Pink: LEAS)), announced results presented at the European Society of ...

COVERING YOUR COMMUNITY. PEOPLE IN BOYNTON BEACH CAME TOGETHER YESTERDAY TO CELEBRATE A GOOD CAUSE. OUR MORNING ANCHOR TRAFFIC ANCHOR YASMINE JULMISSE EMCEED THE 2024 WALK TO DEFEAT ALS, CELEBRATING ...